We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 13, 2019

Growth Characteristics and Therapeutic Decision Markers in VHL Disease Patients With RCC

Orphanet Journal of Rare Diseases


Additional Info

Disclosure statements are available on the authors' profiles:

Orphanet Journal of Rare Diseases
Growth Characteristics and Therapeutic Decision Markers in Von Hippel-Lindau Disease Patients With Renal Cell Carcinoma
Orphanet J Rare Dis 2019 Oct 28;[EPub Ahead of Print], P Schuhmacher, E Kim, F Hahn, P Sekula, CA Jilg, C Leiber, HP Neumann, W Schultze-Seemann, G Walz, S Zschiedrich

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading